Paclitaxel [33069-62-4]
Katalog-Nummer HY-B0015-50mg
Size : 50mg
Marke : MedChemExpress
Paclitaxel est un agent antinéoplasique naturel et stabilise la polymérisation de la tubuline. Paclitaxel peut provoquer à la fois l'arrêt mitotique et la mort cellulaire apoptotique. Paclitaxel induit également l'autophagie.
Paclitaxel ist ein natürlich vorkommendes antineoplastisches Mittel und stabilisiert die tubulinpolymerisation. Paclitaxel kann sowohl einen mitotischen Stillstand als auch apoptotic Zelltod verursachen. Paclitaxel induziert auch autophagy.
Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
Paclitaxel Chemische Struktur
CAS. Nr. : 33069-62-4
* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.
This product is a controlled substance and not for sale in your territory.
- Paclitaxel (PTX; 3.125, 6.25, 12.5, 25, 50, 100 nM; 48 h) reduces the viability of Hela, SiHa, and C33A cells in a dose-dependent manner.(3.125 nM for Hela cells, 100 nM for SiHa and C33A cells)
- Paclitaxel (PTX; 50 nM; 48 h) increases the expression of Cleaved-caspase-9 and Cleaved-caspase-3 in Hela cells.
- Paclitaxel (25, 50 μM; 24 h) significantly increases the expression of caspase-3 in PK-15 cells.
- Paclitaxel (PTX; 0‑100 nM; 72 h) inhibits the viability of MDA‑MB‑231cells.
- Paclitaxel (CPT; 10-6 -12-10 M; 72 h) demonstrates a strong antitumor activity and an inhibitory of proliferation (IC50 = 6.28 nM) in U937 cells.
- Western blot image and statistical analysis of phosphorylated γH2AX levels in HT-29 cells with different treatments after 48 h. Myricetin and PTX used are 32 μM and 100 nM, respectively.
- The effects of CS1 on polymerized microtubules are also investigated using a cellular tubulin polymer assay. Nocodazole (1 μM) and Paclitaxel (1.5 μM) are used as depolymerization and polymerization controls, respectively.
- Synergistic inhibition of colony formation of ATC cells by E7080 and Paclitaxel. Representative images of colony formation in C643 cells treated with vehicle control (DMSO) or E7080 and Paclitaxel at the indicated concentrations, individually or in combination, are shown in left panel. Quantitative analysis of colony numbers is shown in right panel.
Biologische Aktivität
Reinheit & Dokumentation
Verweise
Kundenbewertung
Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy. | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
In Vitro | Paclitaxel (20 nM; 48 hours) induces programmed cell death and exists a block at the G2/M phase of the cell cycle. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Apoptosis Analysis
Cell Cycle Analysis
Western Blot Analysis
| ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
In Vivo | Paclitaxel (1-20 mg/kg; i.p.; 1 time/2 days for five cycles) obviously induces liver metastases at the low-Paclitaxel group with little influence on primary tumor growth. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||||||||||
| |||||||||||||||||||||||||
853.91 | |||||||||||||||||||||||||
C47H51NO14 | |||||||||||||||||||||||||
33069-62-4 | |||||||||||||||||||||||||
Solid | |||||||||||||||||||||||||
White to off-white | |||||||||||||||||||||||||
O=C(C1=CC=CC=C1)N[C@@H](C2=CC=CC=C2)[C@H](C(O[C@@H]3C(C)=C([C@@H](OC(C)=O)C([C@@]4(C)[C@]([C@@](CO5)(OC(C)=O)[C@@]5(14)C[C@@H]4O)(14)[C@@H]6OC(C7=CC=CC=C7)=O)=O)C(C)(C)[C@@]6(O)C3)=O)O | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
Room temperature in continental US; may vary elsewhere. | |||||||||||||||||||||||||
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) | |||||||||||||||||||||||||
In Vitro: DMSO : 100 mg/mL (117.11 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) H2O : < 0.1 mg/mL (insoluble) Preparing Stock Solutions
View the Complete Stock Solution Preparation Table * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol) Concentration (start) × Volume (start) = Concentration (final) × Volume (final) This equation is commonly abbreviated as: C1V1 = C2V2 In Vivo: Select the appropriate dissolution method based on your experimental animal and administration route. For the following dissolution methods, please ensure to first prepare a clear stock solution using an and then sequentially add co-solvents:
For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
In Vivo Dissolution Calculator Please enter the basic information of animal experiments: Dosage mg/kgAnimal weight Dosing volume Number of animals Recommended: Prepare an additional quantity of animals to account for potential losses during experiments. Please enter your animal formula composition: % DMSO + % + % Tween-80 + % Saline The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE). Calculation results: Working solution concentration: mg/mL Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL). *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE). Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline. If the continuous dosing period exceeds half a month, please choose this protocol carefully. Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution. | |||||||||||||||||||||||||
|
-
[1]. Choi YH, et al. Paclitaxel-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells. Oncol Rep. 2012 Dec;28(6):2163-9.
[2]. Dziadyk JM, et al. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest. Anticancer Res. 2004 Jan-Feb;24(1):27-36.
[3]. Li Q, et al. Low doses of paclitaxel enhance liver metastasis of breast cancer cells in the mouse model. FEBS J. 2016 Aug;283(15):2836-52.
[4]. Pan Z, et al. Paclitaxel attenuates Bcl-2 resistance to apoptosis in breast cancer cells through an endoplasmic reticulum-mediated calciumrelease in a dosage dependent manner. Biochem Biophys Res Commun. 2013 Feb 13. pii: S0006-291X(13)00259-3.
[5]. Cadamuro M, et al. Low dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma. Cancer Res. 2016 Jun 21.
[6]. Li Q, et al. Low doses of paclitaxel enhance liver metastasis of breast cancer cells in the mouse model. FEBS J. 2016 Jun 16.
[7]. Yilmaz E, et al. Sensory neuron subpopulation-specific dysregulation of intracellular calcium in a rat model of chemotherapy-induced peripheral neuropathy. Neuroscience. 2015 Aug 6;300:210-8.
[8]. Jing C, et al. E7080 enhances the antitumor effects of paclitaxel in anaplastic thyroid cancer. Am J Cancer Res. 2017 Apr 1;7(4):903-912.
* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
---|
DMSO | 1 mM | 1.1711 mL | 5.8554 mL | 11.7108 mL | 29.2771 mL |
5 mM | 0.2342 mL | 1.1711 mL | 2.3422 mL | 5.8554 mL | |
10 mM | 0.1171 mL | 0.5855 mL | 1.1711 mL | 2.9277 mL | |
15 mM | 0.0781 mL | 0.3904 mL | 0.7807 mL | 1.9518 mL | |
20 mM | 0.0586 mL | 0.2928 mL | 0.5855 mL | 1.4639 mL | |
25 mM | 0.0468 mL | 0.2342 mL | 0.4684 mL | 1.1711 mL | |
30 mM | 0.0390 mL | 0.1952 mL | 0.3904 mL | 0.9759 mL | |
40 mM | 0.0293 mL | 0.1464 mL | 0.2928 mL | 0.7319 mL | |
50 mM | 0.0234 mL | 0.1171 mL | 0.2342 mL | 0.5855 mL | |
60 mM | 0.0195 mL | 0.0976 mL | 0.1952 mL | 0.4880 mL | |
80 mM | 0.0146 mL | 0.0732 mL | 0.1464 mL | 0.3660 mL | |
100 mM | 0.0117 mL | 0.0586 mL | 0.1171 mL | 0.2928 mL |
- Cytoskeleton Cell Cycle/DNA Damage Antibody-drug Conjugate/ADC Related Apoptosis Autophagy
- Microtubule/Tubulin ADC Cytotoxin Apoptosis Autophagy
-
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.
Keywords:
Paclitaxel33069-62-4Microtubule/TubulinADC CytotoxinApoptosisAutophagyADC PayloadInhibitorinhibitorinhibit
Ihre kürzlich angesehenen Produkte:
Online-Anfrage
Your information is safe with us. * Required Fields.
Massenanfrage
Inquiry Information
- Produktname:
- Paclitaxel
- Art. -Nr.:
- HY-B0015
- Menge:
- MCE Japan Authorized Agent: